Anti-GPRC5D BsAb as a bridge to... | American Society of Hematology

Anti-GPRC5D BsAb as a bridge to anti-BCMA CAR-T therapy. CD3, cluster of differentiation 3.

Anti-GPRC5D BsAb as a bridge to anti-BCMA CAR-T therapy. CD3, cluster of differentiation 3.

This Feature Is Available To Subscribers Only

Sign In or Create an Account